Actinium Pharmaceuticals
ATNM
#9859
Rank
NZ$75.45 M
Marketcap
NZ$2.42
Share price
-2.10%
Change (1 day)
6.98%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -NZ$74.83 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$72.77 Million, an increase over its 2023 earnings that were of -NZ$89.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$74.83 Million2.82%
2024 -NZ$72.77 Million-18.87%
2023 -NZ$89.7 Million52.24%
2022 -NZ$58.92 Million36.61%
2021 -NZ$43.13 Million11.48%
2020 -NZ$38.69 Million1.46%
2019 -NZ$38.13 Million-7.37%
2018 -NZ$41.17 Million-11.46%
2017 -NZ$46.5 Million10.67%
2016 -NZ$42.01 Million15.7%
2015 -NZ$36.31 Million-14.86%
2014 -NZ$42.65 Million129.19%
2013 -NZ$18.61 Million-8.55%
2012 -NZ$20.35 Million
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 Million-39.8%
2008 -NZ$0.05 Million120.29%
2007 -NZ$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-NZ$64.26 Million-15.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.17 B-1,635.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.6 M-111.26%๐Ÿ‡บ๐Ÿ‡ธ USA